Design and manufacture photonics-based solutions for industrial processing and medical applications. Now — the numbers.
This is an established company with proven profits.
If every debt were paid off today, $39.3M would still be left in the vault — a solid cushion for hard times.
The market pays 40.8× for every dollar this company earns in a year — a price that already assumes things go well.
Against companies in its own sector, it looks cheaper than 53% of them.
No analyst target is on record for this company.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit indicators sit around the sector average.
Debt is low and cash is strong; the finances stand solid.
The price isn’t cheap next to earnings — that’s why this grade sits in the middle.
Clearly below the class average.
The price is looking for direction — no strong breakout, no collapse.
Growth: Sales growth trails the sector average.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
The stock trades below its recent peak — about 13% off the top. A pullback, not a collapse.
There is $380.9M in the vault; even if every debt were paid off, $39.3M would remain.
It met or beat analyst expectations in 7 of the last 8 quarters — consistency is a promise kept.
It pays out $2.34 per share each year — regular cash for whoever holds the stock.
The company’s market value is 41 times its annual profit. Even a small disappointment could hit the price hard.
The growth engine is running at low revs right now. Report-card grade: 28/100.
We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the growth trend, the revenue breakdown.